Industrial partnerships, go-to-market, first customers, industrial pitch — articles written by a deeptech founder for deeptech founders.
A sector is not a target. Here's a concrete framework for going from "the pharmaceutical industry" to a named shortlist of 20 companies and the right person inside each one.
What happens in the room after you leave matters more than the meeting itself. Here's what industrial buyers are actually evaluating — and what consistently triggers silence.
Most deeptech value propositions are written for scientists or investors. Neither is your industrial buyer. Here's the five-element structure that works for the people who can actually sign a deal.
Every week, thousands of deeptech founders send cold messages to industrial directors. Almost none get a meaningful response. This is not a copy problem — it's structural. Here's the approach that actually works.
Most deeptech founders see their IP portfolio as a legal shield. Industrial buyers see it as a signal of credibility and a negotiation structure. Here's how to use your patents as an active commercial lever.
Most deeptech founders answer this sequencing question reactively. Here's a framework for deciding deliberately — and avoiding the traps each scenario contains.
Waiting for a finished product before commercialising is the most costly mistake in deeptech. There are four categories of assets you can monetise today.
Industrial partnerships aren't reserved for mature technologies. An overview of the formats suited to early-stage deeptech startups.
From waiting for the perfect product to a poorly calibrated pitch: the five most common mistakes and how to avoid them.
What convinces an investor often worries an industrial director. Understanding this difference changes everything about your commercial approach.